Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04605211 · ClinicalTrials.gov registry record · NA
A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors
A NA study of Myeloproliferative Neoplasm and Chronic Myeloid Leukemia, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT04605211: Completed NA study of Myeloproliferative Neoplasm and Chronic Myeloid Leukemia, sponsored by University of California, San Francisco.
NCT04605211 is a NA study of Myeloproliferative Neoplasm and Chronic Myeloid Leukemia that has completed, run by University of California, San Francisco. The registered enrollment target is 47 participants, below the 84-participant average among 40 other Myeloproliferative Neoplasm trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04605211, a NA study of Myeloproliferative Neoplasm and Chronic Myeloid Leukemia, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial looks at how well a distress reduction intervention, called "Being Present", works to improve the quality of life of patients with BCR-ABL-negative myeloproliferative neoplasms (MPNs) or chronic phase chronic myeloid leukemia (CP-CML) who are taking tyrosine kinase inhibitors (TKIs) and their caregivers. Mindfulness meditation is the practice of repeatedly bringing attention back to the immediate experience and may help people cope with various types of illness, stress, and worry. This may help patients and caregivers to gradually learn to disconnect from reacting to and dwelling on the past and future and instead fully experiencing the present moment.
Primary Outcome
The frequency of primary symptoms will be categorized and assessed by semi-structured qualitative interviews.
Conditions Studied
Interventions
- BEHAVIORAL Online Mindfulness Meditation
- OTHER Internet-Based Webinars
Study Locations (1)
California
- University of California San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2020-09-18 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
What the finished NCT04605211 record still lists
NCT04605211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 47 participants, a relatively small participant target, below the 84-participant average among 40 other Myeloproliferative Neoplasm trials with a reported enrollment target (44% lower).
The record links to 3 conditions, with Myeloproliferative Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Online Mindfulness Meditation is the first listed.
NCT04605211 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04605211 about?
NCT04605211 is a clinical study titled "A Distress Reduction Intervention for Patients With BCR-ABL-Negative MPNs or CML on Tyrosine Kinase Inhibitors". This trial looks at how well a distress reduction intervention, called "Being Present", works to improve the quality of life of patients with BCR-ABL-negative myeloproliferative neoplasms (MPNs) or chronic phase chronic myeloid leukemia (CP-CML) who are taking tyrosine kinase inhibitors (TKIs) and t...
What is the current status of trial NCT04605211?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2020-09-18. Estimated completion is 2022-09-30.
What conditions does trial NCT04605211 study?
This clinical trial studies the following conditions: Myeloproliferative Neoplasm, Chronic Myeloid Leukemia, Chronic Phase Chronic Myelogenous Leukemia.
What interventions are being tested in trial NCT04605211?
The interventions under investigation include: Online Mindfulness Meditation (BEHAVIORAL), Internet-Based Webinars (OTHER).
Who is sponsoring clinical trial NCT04605211?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04605211 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myeloproliferative Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04605211's enrollment target sits among peer trials
47 24th of 40 higher than 17 of 40 other Myeloproliferative Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myeloproliferative Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
RECRUITING · NA
-
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
RECRUITING · NA
-
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
RECRUITING · NA
-
Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study
ACTIVE NOT RECRUITING · NA
-
Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative Neoplasm
COMPLETED · NA
-
Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI